Safety and efficacy of recombinant granulocyte colony-stimulating factor as an adjunctive therapy for Streptococcus pneumoniae meningitis in non-neutropenic adult patients: a pilot study.

de Lalla, F; Nicolin, R; Lazzarini, L

de Lalla, F; Nicolin, R; Lazzarini, L.

Affiliation

de Lalla F; Department of Infectious Diseases, S. Bortolo Hospital, via Rodolfi, 36100 Vicenza, Italy. fdl.vi@gpnet.it

J Antimicrob Chemother ; 46(5): 843-6, 2000 Nov.

Article in En | MEDLINE | ID: mdl-11062212

Subject(s)

Granulocyte Colony-Stimulating Factor/therapeutic use; Meningitis, Pneumococcal/drug therapy; Streptococcus pneumoniae; Adult; Aged; Anti-Inflammatory Agents/therapeutic use; Cefotaxime/therapeutic use; Cephalosporins/therapeutic use; Chemotherapy, Adjuvant; Dexamethasone/therapeutic use; Drug Therapy, Combination; Female; Humans; Male; Meningitis, Pneumococcal/cerebrospinal fluid; Middle Aged; Pilot Projects; Recombinant Proteins

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Streptococcus pneumoniae / Granulocyte Colony-Stimulating Factor / Meningitis, Pneumococcal Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Antimicrob Chemother Year: 2000 Document type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links